β-Blockers Commonly Used for Ischemic Heart Disease
| Drug | β-Receptor Selectivity | Dose |
|---|
| Propranolol | β1 and β2 | 20–80 mg bid | | Metoprolol | β1 | 50–200 mg bid | | Atenolol | β1 | 50–200 mg daily | | Nebivolol | β1 | 5–40 mg daily | | Nadolol | β1 and β2 | 40–80 mg daily | | Timolol | β1 and β2 | 10–30 mg tid | | Acebutolola | β1 | 200–600 mg bid | | Bisoprolol | β1 | 10–20 mg daily | | Esmolol (IV) | β1 | 50–300 µg/kg/min | | Labetalol | Combined α, β1, β2 | 200–600 mg bid | | Pindolola | β1 and β2 | 2.5–7.5 mg tid | | Carvedilol | Combined α, β1, β2 | 3.125–25 mg bid |
|
a β-Blockers with intrinsic sympathomimetic activity.